Baxter Nicholas W 4
4 · Lexaria Bioscience Corp. · Filed Dec 23, 2019
Insider Transaction Report
Form 4
Baxter Nicholas W
Director
Transactions
- Exercise/Conversion
common shares
2019-12-20$0.10/sh+110,000$11,000→ 330,000 total - Exercise/Conversion
Stock Options
2019-12-20$0.10/sh−110,000$11,000→ 150,000 totalExercise: $0.10From: 2014-12-23Exp: 2019-12-23→ Common Shares (110,000 underlying)
Holdings
- 260,000
Stock Options
Exercise: $0.99From: 2019-05-06Exp: 2024-05-06→ Common Shares (150,000 underlying) - 110,000
Stock Options
Exercise: $0.10From: 2014-12-23Exp: 2019-12-23→ Common Shares (110,000 underlying) - 220,000
common shares